132 related articles for article (PubMed ID: 32160053)
21. Personal History of Premenopausal Breast Cancer as a Risk Factor for Referral to Screening Breast MRI.
Destounis S; Arieno A; Morgan R
Acad Radiol; 2016 Mar; 23(3):353-7. PubMed ID: 26774742
[TBL] [Abstract][Full Text] [Related]
22. The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.
Vreemann S; Gubern-Mérida A; Borelli C; Bult P; Karssemeijer N; Mann RM
PLoS One; 2018; 13(1):e0191399. PubMed ID: 29351560
[TBL] [Abstract][Full Text] [Related]
23. An Abbreviated Protocol for High-risk Screening Breast Magnetic Resonance Imaging: Impact on Performance Metrics and BI-RADS Assessment.
Panigrahi B; Mullen L; Falomo E; Panigrahi B; Harvey S
Acad Radiol; 2017 Sep; 24(9):1132-1138. PubMed ID: 28506511
[TBL] [Abstract][Full Text] [Related]
24. Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.
Sippo DA; Rutledge GM; Burk KS; Mercaldo SF; Dontchos BN; Edmonds CE; Lehman CD
AJR Am J Roentgenol; 2019 Mar; 212(6):1412-1418. PubMed ID: 30888867
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of screening mammography according to menstrual cycle among Asian women.
Kwon MR; Chang Y; Youn I; Kook SH; Cho Y; Park B; Ryu S
Breast Cancer Res Treat; 2023 Nov; 202(2):357-366. PubMed ID: 37642882
[TBL] [Abstract][Full Text] [Related]
26. Improving outcomes of screening breast MRI with practice evolution: initial clinical experience with 3T compared to 1.5T.
Lourenco AP; Donegan L; Khalil H; Mainiero MB
J Magn Reson Imaging; 2014 Mar; 39(3):535-9. PubMed ID: 23720144
[TBL] [Abstract][Full Text] [Related]
27. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.
Hambly NM; Liberman L; Dershaw DD; Brennan S; Morris EA
AJR Am J Roentgenol; 2011 Jan; 196(1):218-24. PubMed ID: 21178070
[TBL] [Abstract][Full Text] [Related]
28. Should breast MRI be performed with adjustment for the phase in patients' menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients' menstrual cycle.
Uematsu T; Kasami M; Watanabe J
Eur J Radiol; 2012 Jul; 81(7):1539-42. PubMed ID: 21592704
[TBL] [Abstract][Full Text] [Related]
29. Pilot study of quantitative analysis of background enhancement on breast MR images: association with menstrual cycle and mammographic breast density.
Scaranelo AM; Carrillo MC; Fleming R; Jacks LM; Kulkarni SR; Crystal P
Radiology; 2013 Jun; 267(3):692-700. PubMed ID: 23418005
[TBL] [Abstract][Full Text] [Related]
30. Differences in measured mammographic density in the menstrual cycle.
Hovhannisyan G; Chow L; Schlosser A; Yaffe MJ; Boyd NF; Martin LJ
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1993-9. PubMed ID: 19567508
[TBL] [Abstract][Full Text] [Related]
31. Screening Breast MRI in Patients Previously Treated for Breast Cancer: Diagnostic Yield for Cancer and Abnormal Interpretation Rate.
Giess CS; Poole PS; Chikarmane SA; Sippo DA; Birdwell RL
Acad Radiol; 2015 Nov; 22(11):1331-7. PubMed ID: 26142951
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women.
Clendenen TV; Kim S; Moy L; Wan L; Rusinek H; Stanczyk FZ; Pike MC; Zeleniuch-Jacquotte A
Magn Reson Imaging; 2013 Jan; 31(1):1-9. PubMed ID: 22898693
[TBL] [Abstract][Full Text] [Related]
33. Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes.
Benndorf M; Baltzer PA; Vag T; Gajda M; Runnebaum IB; Kaiser WA
Acta Radiol; 2010 Sep; 51(7):715-21. PubMed ID: 20707656
[TBL] [Abstract][Full Text] [Related]
34. Auditing a breast MRI practice: performance measures for screening and diagnostic breast MRI.
Niell BL; Gavenonis SC; Motazedi T; Chubiz JC; Halpern EP; Rafferty EA; Lee JM
J Am Coll Radiol; 2014 Sep; 11(9):883-9. PubMed ID: 24787571
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and Predictive Value of BI-RADS 3, 4, and 5 Lesions Detected on Breast MRI: Correlation with Study Indication.
Chikarmane SA; Tai R; Meyer JE; Giess CS
Acad Radiol; 2017 Apr; 24(4):435-441. PubMed ID: 27955878
[TBL] [Abstract][Full Text] [Related]
36. Relationship Between Breast Ultrasound Background Echotexture and Magnetic Resonance Imaging Background Parenchymal Enhancement and the Effect of Hormonal Status Thereon.
Kim SJ; Jung HK; Han BK; Lee JH; Oh KS; Lee JS; Lee Y
Ultrasound Q; 2020 Jun; 36(2):179-191. PubMed ID: 32511210
[TBL] [Abstract][Full Text] [Related]
37. Performance of Screening Breast MRI across Women with Different Elevated Breast Cancer Risk Indications.
Sippo DA; Burk KS; Mercaldo SF; Rutledge GM; Edmonds C; Guan Z; Hughes KS; Lehman CD
Radiology; 2019 Jul; 292(1):51-59. PubMed ID: 31063080
[TBL] [Abstract][Full Text] [Related]
38. Background Breast Parenchymal Signal During Menstrual Cycle on Diffusion-Weighted MRI: A Prospective Study in Healthy Premenopausal Women.
Kim YS; Yun B; Chu AJ; Lee SH; Shin HJ; Kim SM; Jang M; Shin SU; Moon WK
Korean J Radiol; 2024 Jun; 25(6):511-517. PubMed ID: 38807333
[TBL] [Abstract][Full Text] [Related]
39. Time to enhancement of breast lesions and normal breast parenchyma in light of menopausal status and menstrual cycle for ultrafast dynamic contrast-enhanced MRI using compressed sensing.
Yamaguchi K; Nakazono T; Egashira R; Fukui S; Baba K; Hamamoto T; Aishima S; Maruyama K; Nickel D; Irie H
Magn Reson Imaging; 2023 Feb; 96():102-107. PubMed ID: 36375761
[TBL] [Abstract][Full Text] [Related]
40. Breast Background Parenchymal Enhancement on Screening Magnetic Resonance Imaging in Women Who Received Chest Radiotherapy for Childhood Hodgkin's Lymphoma.
Zeng L; Lo G; Moshonov H; Liang J; Hodgson D; Crystal P
Acad Radiol; 2016 Feb; 23(2):168-75. PubMed ID: 26546383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
